company's pharmaceutical business.
The Cambridge, Mass.-based company offers the FoundationOne cancer panel for solid tumors and the
FoundationOne Heme for blood-based cancers. Together, the tests represent ... based cancer
diagnostics space. For example, non-profit outfit Paradigm recently began offering a cancer panel based on DNA
and RNA sequencing, as Clinical Sequencing News reported.
"As more labs